|
US101A
(en)
|
|
1836-12-06 |
|
Method of jcakibtg and furling iw sails fob ships |
|
US5530A
(en)
|
|
1848-04-25 |
|
Horse-power |
|
US5208036A
(en)
|
1985-01-07 |
1993-05-04 |
Syntex (U.S.A.) Inc. |
N-(ω, (ω-1)-dialkyloxy)- and N-(ω, (ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
EP0940468A1
(en)
|
1991-06-14 |
1999-09-08 |
Genentech, Inc. |
Humanized antibody variable domain
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
DE69330523D1
(de)
|
1992-08-21 |
2001-09-06 |
Vrije Universiteit Brussel Bru |
Immunoglobuline ohne leichte ketten
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
DE69318420T2
(de)
|
1992-12-14 |
1999-01-28 |
Naamloze Vennootschap Innogenetics S.A., Gent |
Monoklonale antikörper gegen das mikrotubulusassoziierte tauprotein,hybridomen, die diese antikörper sezernieren, antigenerkennung durch diese monoklonalen antikörper und deren verwendung
|
|
DK0735893T3
(da)
|
1993-09-14 |
2009-03-09 |
Pharmexa Inc |
PAN DR-bindende peptider til styrkelse af immunsvaret
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5786464C1
(en)
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
US7427392B1
(en)
|
1994-11-14 |
2008-09-23 |
Elan Pharmaceuticals, Inc. |
Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
DE19539493A1
(de)
|
1995-10-24 |
1997-04-30 |
Thomae Gmbh Dr K |
Starker homologer Promotor aus Hamster
|
|
US5834597A
(en)
|
1996-05-20 |
1998-11-10 |
Protein Design Labs, Inc. |
Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
ATE441432T1
(de)
|
1997-03-10 |
2009-09-15 |
Ottawa Hospital Res Inst |
Verwendung von nicht-methyliertem cpg dinukleotid in kombination mit aluminium als adjuvantien
|
|
US5888809A
(en)
|
1997-05-01 |
1999-03-30 |
Icos Corporation |
Hamster EF-1α transcriptional regulatory DNA
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
BR0007956A
(pt)
|
1999-02-05 |
2002-04-09 |
Samsung Electronics Co Ltd |
Método de recuperação de textura por imagem e equipamento para essa finalidade, e meio legìvel por computador
|
|
AT500379B8
(de)
|
2001-02-02 |
2009-08-15 |
Axon Neuroscience |
Tau-proteine
|
|
US6881557B2
(en)
|
2001-07-12 |
2005-04-19 |
Arrowsmith Technologies Llp |
Super humanized antibodies
|
|
JP4393382B2
(ja)
|
2002-08-14 |
2010-01-06 |
三菱化学株式会社 |
中枢性タウ蛋白質特異的抗体
|
|
JP4344325B2
(ja)
|
2002-11-29 |
2009-10-14 |
ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト |
新規なネオマイシンホスホトランスフェラーゼ遺伝子及び高生産組換え細胞の選抜方法
|
|
US7847146B2
(en)
|
2003-03-28 |
2010-12-07 |
Baylor College Of Medicine |
Model for neurodegenerative disorders
|
|
DE10338531A1
(de)
|
2003-08-19 |
2005-04-07 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Reklonierung von Produktionszellen
|
|
US20050132424A1
(en)
|
2003-10-21 |
2005-06-16 |
Envivo Pharmaceuticals, Inc. |
Transgenic flies expressing Abeta42-Dutch
|
|
JP2008520186A
(ja)
|
2004-10-01 |
2008-06-19 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
哺乳類ｅａｇ１イオンチャネルタンパク質に対する新規の抗体
|
|
KR101235658B1
(ko)
|
2004-11-10 |
2013-02-21 |
베링거 잉겔하임 파르마 게엠베하 운트 코 카게 |
Ｃｈｏ 세포에 대한 세포 뱅킹 전략을 최적화하기 위한 유동 세포측정 분석의 용도
|
|
WO2006067122A2
(en)
|
2004-12-20 |
2006-06-29 |
Crucell Holland B.V. |
Binding molecules capable of neutralizing west nile virus and uses thereof
|
|
AU2005322869B2
(en)
|
2004-12-30 |
2011-05-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Framework residue substituted humanized COL-1 antibodies and their use
|
|
US8012936B2
(en)
|
2006-03-29 |
2011-09-06 |
New York University |
Tau fragments for immunotherapy
|
|
AU2007261584A1
(en)
|
2006-06-16 |
2007-12-27 |
Envivo Pharmaceutical Inc. |
Transgenic flies expressing tau and amyloid precursor fragment
|
|
US8301398B2
(en)
|
2006-06-22 |
2012-10-30 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
|
US20080124760A1
(en)
|
2006-07-26 |
2008-05-29 |
Barbara Enenkel |
Regulatory Nucleic Acid Elements
|
|
WO2008022153A2
(en)
|
2006-08-14 |
2008-02-21 |
The Regents Of The University Of California |
Inhibitors of pde4 and methods of use
|
|
NZ578064A
(en)
|
2006-12-01 |
2012-01-12 |
Medarex Inc |
Human antibodies that bind cd22 and uses thereof
|
|
JP5558834B2
(ja)
|
2007-02-23 |
2014-07-23 |
ヤンセン アルツハイマー イミュノセラピー |
シヌクレイノパチーおよびアミロイド形成疾患（ａｍｙｌｏｉｄｏｇｅｎｉｃｄｉｓｅａｓｅ）の予防および処置
|
|
KR20100015363A
(ko)
|
2007-03-02 |
2010-02-12 |
베링거 잉겔하임 파르마 게엠베하 운트 코 카게 |
단백질 생산의 개선
|
|
EP2031064A1
(de)
|
2007-08-29 |
2009-03-04 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Verfahren zur Steigerung von Proteintitern
|
|
JP2009056790A
(ja)
|
2007-09-03 |
2009-03-19 |
Takao Otogawa |
ファイル用ポケット
|
|
TW200927761A
(en)
|
2007-09-26 |
2009-07-01 |
U3 Pharma Ag |
Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
|
|
US8263743B2
(en)
|
2007-11-13 |
2012-09-11 |
Teva Biopharmaceuticals Usa, Inc. |
Humanized antibodies against TL1A
|
|
CR20170001A
(es)
|
2008-04-28 |
2017-08-10 |
Genentech Inc |
Anticuerpos anti factor d humanizados
|
|
JP2010014691A
(ja)
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び／又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
|
NO2321351T3
(OSRAM)
|
2008-08-18 |
2018-03-31 |
|
|
|
US9605054B2
(en)
|
2009-02-23 |
2017-03-28 |
The Board Of Trustees Of The University Of Illinois |
Composition and method for treating a tauopathy
|
|
NZ621170A
(en)
|
2009-05-13 |
2015-08-28 |
Genzyme Corp |
Anti-human cd52 immunoglobulins
|
|
EP2440234A4
(en)
|
2009-06-10 |
2013-11-06 |
Univ New York |
IMMUNOLOGICAL AIMING OF PATHOLOGICAL TAU PROTEINS
|
|
US20110045534A1
(en)
|
2009-08-20 |
2011-02-24 |
Cell Signaling Technology, Inc. |
Nucleic Acid Cassette For Producing Recombinant Antibodies
|
|
WO2011026031A1
(en)
|
2009-08-28 |
2011-03-03 |
The Board Of Regents Of The University Of Texas System |
Antibodies that bind tau oligomers
|
|
WO2011053565A2
(en)
|
2009-10-29 |
2011-05-05 |
Biomedical Sciences Research Centre "Alexander Fleming" |
Compositions and methods for detecting a tauopathy
|
|
WO2011075636A2
(en)
|
2009-12-18 |
2011-06-23 |
Amgen Inc. |
Wise binding agents and epitopes
|
|
EP2522360B1
(en)
|
2010-01-08 |
2016-11-16 |
Kyoto University |
Vaccine for treatment of tauopathy
|
|
KR20130004579A
(ko)
|
2010-02-23 |
2013-01-11 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
|
JP2011201655A
(ja)
|
2010-03-25 |
2011-10-13 |
Minoru Industrial Co Ltd |
ダンボールテープ貼付機
|
|
US8987419B2
(en)
|
2010-04-15 |
2015-03-24 |
AbbVie Deutschland GmbH & Co. KG |
Amyloid-beta binding proteins
|
|
EP2560681A4
(en)
|
2010-04-22 |
2013-09-25 |
Janssen Alzheimer Immunotherap |
USE OF TAU FOR MONITORING IMMUNOTHERAPY
|
|
ITRM20100320A1
(it)
|
2010-06-11 |
2011-12-11 |
Consiglio Nazionale Ricerche |
Metodo per la diagnostica e il trattamento delle taupatie
|
|
US20120023911A1
(en)
|
2010-07-28 |
2012-02-02 |
Gm Global Technology Operations, Inc. |
Detection of exhaust particulate filter substrate failure
|
|
TR201812636T4
(tr)
|
2010-10-11 |
2018-09-21 |
Biogen Int Neuroscience Gmbh |
İnsan anti-tau antikorları.
|
|
US8741298B2
(en)
|
2011-02-07 |
2014-06-03 |
Neotope Biosciences Limited |
APOE immunotherapy
|
|
US8697076B2
(en)
|
2011-04-27 |
2014-04-15 |
Northwestern University |
Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies
|
|
GB201109238D0
(en)
|
2011-06-01 |
2011-07-13 |
Antitope Ltd |
Antibodies
|
|
GB201111361D0
(en)
|
2011-07-04 |
2011-08-17 |
Nordic Bioscience As |
Biochemical markers for neurodegenerative conditions
|
|
GB201112056D0
(en)
|
2011-07-14 |
2011-08-31 |
Univ Leuven Kath |
Antibodies
|
|
SG11201400916XA
(en)
|
2011-08-22 |
2014-06-27 |
Cangene Corp |
Clostridium difficile antibodies
|
|
BR112014006376B1
(pt)
|
2011-09-19 |
2021-07-27 |
Axon Neuroscience Se |
Anticorpo isolado que se liga a um ou mais epítopos tau, ácido nucleico, vetor, composição farmacêutica, artigo de fabricação, dispositivo médico, método in vitro para diagnosticar ou triar um indivíduo quanto à presença de doença de alzheimer ou de uma tauopatia relacionada e usos do referido anticorpo
|
|
TW201326209A
(zh)
|
2011-09-30 |
2013-07-01 |
Chugai Pharmaceutical Co Ltd |
具有促進抗原清除之ＦｃＲｎ結合域的治療性抗原結合分子
|
|
CN108034005B
(zh)
|
2011-10-07 |
2021-06-25 |
Ac免疫有限公司 |
识别Tau的磷酸化特异抗体
|
|
WO2013059786A1
(en)
|
2011-10-21 |
2013-04-25 |
The Ohio State University |
Methylated peptides derived from tau protein and their antibodies for diagnosis and therapy of alzheimer's disease
|
|
HRP20180928T1
(hr)
|
2012-03-28 |
2018-07-27 |
Sanofi |
Protutijela za ligande bradikinin b1 receptora
|
|
WO2013151762A1
(en)
|
2012-04-05 |
2013-10-10 |
Ac Immune S.A. |
Humanized tau antibody
|
|
CA2868327A1
(en)
|
2012-04-18 |
2013-10-24 |
E. I. Du Pont De Nemours And Company |
Multilayered sheet
|
|
DE102012211455A1
(de)
|
2012-07-02 |
2014-01-02 |
Wobben Properties Gmbh |
Handhabungsvorrichtung zum Handhaben einer Rotorblattform zum Fertigen eines Rotorblattes einer Windenergieanlage
|
|
EP3838921A3
(en)
|
2012-07-03 |
2021-09-01 |
Washington University |
Antibodies to tau
|
|
NZ630542A
(en)
|
2012-08-16 |
2017-06-30 |
Ipierian Inc |
Methods of treating a tauopathy
|
|
US20140056901A1
(en)
|
2012-08-21 |
2014-02-27 |
The Institute For Molecular Medicine |
Anti-tau antibodies and compositions for and methods of making and using in treatment, diagnosis and monitoring of tauopathies
|
|
JP6324974B2
(ja)
|
2012-10-12 |
2018-05-23 |
アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ |
タウの毒性オリゴマー形態を特異的に認識する抗体ベースの試薬
|
|
US9200068B2
(en)
|
2012-12-18 |
2015-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods related to tauopathy
|
|
CA2896066C
(en)
|
2012-12-21 |
2022-07-12 |
Biogen Ma Inc. |
Human anti-tau antibodies
|
|
US8980270B2
(en)
|
2013-01-18 |
2015-03-17 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
|
US9364191B2
(en)
|
2013-02-11 |
2016-06-14 |
University Of Rochester |
Method and apparatus of spectral differential phase-contrast cone-beam CT and hybrid cone-beam CT
|
|
CA2902026C
(en)
*
|
2013-03-13 |
2023-08-29 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
CA2939692C
(en)
|
2013-03-15 |
2022-10-18 |
The Trustees Of The University Of Pennsylvania |
Blood biomarkers that predict persistent cognitive dysfunction after concussion
|
|
AU2014240063B2
(en)
|
2013-03-15 |
2019-04-11 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for the generation and use of conformation-specific antibodies
|
|
HK1225740A1
(zh)
|
2013-08-22 |
2017-09-15 |
Acceleron Pharma Inc. |
TGF-β受体II型变体及其用途
|
|
MX384909B
(es)
|
2013-11-27 |
2025-03-14 |
Ipierian Inc |
Un anticuerpo anti-tau para usarse al tratar una tauopatía.
|
|
US20160333063A1
(en)
|
2013-12-13 |
2016-11-17 |
The General Hospital Corporation |
Soluble high molecular weight (hmw) tau species and applications thereof
|
|
CN112390883A
(zh)
|
2013-12-17 |
2021-02-23 |
基因泰克公司 |
抗cd3抗体及使用方法
|
|
US9629801B2
(en)
|
2014-01-10 |
2017-04-25 |
Wisconsin Alumni Research Foundation |
Blood-brain barrier targeting antibodies
|
|
US20150253341A1
(en)
|
2014-02-10 |
2015-09-10 |
Merck Sharp & Dohme Corp. |
Quantification of tau in biological samples by immunoaffinity enrichment and mass spectrometry
|
|
AU2015279086B2
(en)
|
2014-06-26 |
2021-01-28 |
Janssen Vaccines & Prevention B.V. |
Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
|
|
TWI734975B
(zh)
|
2014-06-27 |
2021-08-01 |
美商Ｃ２Ｎ醫療診斷有限責任公司 |
人類化抗-tau抗體
|
|
SMT202100055T1
(it)
|
2014-11-19 |
2021-03-15 |
Axon Neuroscience Se |
Anticorpi tau umanizzati nella malattia di alzheimer
|
|
CA2874083C
(en)
|
2014-12-05 |
2024-01-02 |
Universite Laval |
Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
|
|
EP3261670A4
(en)
|
2015-02-24 |
2018-08-01 |
Rpeptide, LLC |
Anti-tau antibodies
|
|
PL3303386T3
(pl)
|
2015-06-05 |
2025-03-03 |
Genentech, Inc. |
Przeciwciała anty-tau i sposoby zastosowania
|
|
EP3307320A4
(en)
|
2015-06-12 |
2019-03-06 |
C2N Diagnostics LLC |
Stable formulations of humanized anti-tau antibodies
|
|
AU2016289753C1
(en)
|
2015-07-06 |
2021-08-05 |
UCB Biopharma SRL |
Tau-binding antibodies
|
|
JO3711B1
(ar)
|
2015-07-13 |
2021-01-31 |
H Lundbeck As |
أجسام مضادة محددة لبروتين تاو وطرق استعمالها
|
|
EP3325506A1
(en)
|
2015-07-21 |
2018-05-30 |
BioArctic AB |
Method for treatment of traumatic brain injury targeting aggregated peptides
|
|
US20190330335A1
(en)
|
2015-10-06 |
2019-10-31 |
Alector Llc |
Anti-trem2 antibodies and methods of use thereof
|
|
EP3452508A1
(en)
|
2016-05-02 |
2019-03-13 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
US10752679B2
(en)
|
2016-05-02 |
2020-08-25 |
Prothena Biosciences Limited |
Tau immunotherapy
|
|
PE20190208A1
(es)
|
2016-05-02 |
2019-02-07 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau
|
|
US10947302B2
(en)
|
2016-11-04 |
2021-03-16 |
The Regents Of The University Of California |
Compositions targeting 3-repeat tau for the treatment of neurodegenerative disorders, and methods for making and using them
|
|
TWI787219B
(zh)
|
2016-12-07 |
2022-12-21 |
美商建南德克公司 |
抗-ｔａｕ抗體及使用方法
|
|
CA3045294A1
(en)
|
2016-12-07 |
2018-06-14 |
Genentech, Inc. |
Anti-tau antibodies and methods of use
|
|
WO2018152359A1
(en)
|
2017-02-17 |
2018-08-23 |
Denali Therapeutics Inc. |
Anti-tau antibodies and methods of use thereof
|
|
EP3585430A4
(en)
|
2017-02-21 |
2020-12-09 |
REMD Biotherapeutics, Inc. |
TREATMENT OF CANCER WITH ANTIBODIES THAT BIND TO T-CYTOTOXIC T-LYMPHOCYTES ANTIGEN-4 (CTLA-4)
|
|
JOP20180021A1
(ar)
|
2017-03-16 |
2019-01-30 |
Janssen Biotech Inc |
الأجسام المضادة لتكتلات خيوط بروتين تاو (tau) الحلزونية المزدوجة واستخداماتها
|
|
WO2018183175A1
(en)
|
2017-03-28 |
2018-10-04 |
Genentech, Inc. |
Methods of treating neurodegenerative diseases
|
|
WO2018178077A1
(en)
|
2017-03-28 |
2018-10-04 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
|
MX2019013045A
(es)
|
2017-05-02 |
2020-02-12 |
Prothena Biosciences Ltd |
Anticuerpos que reconocen tau.
|
|
KR20200018502A
(ko)
|
2017-06-16 |
2020-02-19 |
브리스톨-마이어스 스큅 컴퍼니 |
타우병증 치료를 위한 조성물 및 방법
|
|
PE20210115A1
(es)
|
2017-10-16 |
2021-01-19 |
Eisai Randd Man Co Ltd |
Anticuerpos anti-tau y uso de los mismos
|
|
US11591385B2
(en)
|
2017-11-09 |
2023-02-28 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
|
CA3084098A1
(en)
|
2017-12-04 |
2019-06-13 |
Janssen Vaccines & Prevention B.V. |
Binding molecules that specifically bind to tau
|
|
MX2020009935A
(es)
|
2018-03-23 |
2021-01-08 |
Abbvie Deutschland |
Formulaciones acuosas y estables de anticuerpos anti-tau.
|
|
AU2019244481A1
(en)
|
2018-03-28 |
2020-10-01 |
Axon Neuroscience Se |
Antibody-based methods of detecting and treating Alzheimer's disease
|
|
WO2019207159A1
(en)
|
2018-04-27 |
2019-10-31 |
Fondazione Ebri Rita Levi-Montalcini |
Antibody directed against a tau-derived neurotoxic peptide and uses thereof
|
|
UA129124C2
(uk)
|
2018-11-08 |
2025-01-22 |
Протена Біосайєнсіс Лімітед |
Антитіла, що розпізнають тау
|
|
CA3118818A1
(en)
|
2018-11-08 |
2020-05-14 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
WO2020106598A1
(en)
|
2018-11-19 |
2020-05-28 |
The Board Of Regents Of The University Of Texas System |
Tau peptide antigens and antibodies binding thereto for the treatment of tauopathies
|
|
AU2020219374A1
(en)
|
2019-02-08 |
2021-07-01 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
FR3092834B1
(fr)
|
2019-02-15 |
2021-09-24 |
Biorengaz |
Support de culture pour procédé méthanisation
|
|
AU2020231366A1
(en)
|
2019-03-03 |
2021-08-12 |
Prothena Biosciences Limited |
Antibodies recognizing tau
|
|
JP2022526334A
(ja)
|
2019-03-25 |
2022-05-24 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
新たなタウ種を標的化することによるタウオパチー障害の処置の方法
|
|
GB2600599B
(en)
|
2019-07-15 |
2025-05-21 |
Adel Inc |
Anti-Tau antibody and use thereof
|